Better Buy: CRISPR Therapeutics vs. Bluebird Bio By: Motley Fool October 27, 2022 at 09:30 AM EDT These two companies have performed almost equally poorly on the stock market in the past year. Read More >> Related Stocks: Bluebird Bio Crispr Therapeutics Ag